.png){kind=small}
.png){kind=small}
BackTable / OBGYN / Podcast / Episode #58
Understanding Rising Endometrial Cancer Rates
with Dr. Amanda Fader and Dr. Matthew Powell
Gynecologic oncology experts Dr. Matthew Powell from Washington University School of Medicine and Dr. Amanda Fader from Johns Hopkins Hospital discuss the increasing rates of endometrial cancer along with future directions of treatments and screenings.
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2024, June 25). Ep. 58 – Understanding Rising Endometrial Cancer Rates [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Amanda Fader
Dr. Amanda Fader is a professor of gynecology, obstetrics and oncology and a gynecologic oncologist with Johns Hopkins Medicine in Baltimore, Maryland.
Dr. Matthew Powell
Dr. Matthew Powell is a professor of obstetrics and gynecology and a gynecologic oncologist with Washington University in St. Louis, Missouri.
Dr. Amy Park
Dr. Amy Park is the Section Head of Female Pelvic Medicine & Reconstructive Surgery at the Cleveland Clinic, and a co-host of the BackTable OBGYN Podcast.
Synopsis
First, the physicians discuss trends in endometrial cancer rates and delve into the factors driving these trends, such as the obesity epidemic and aging population. They explore the differences between endometrioid and non-endometrioid cancers, along with the impact of racial and geographic disparities. The conversation also covers advances in diagnostics and treatments—including immunotherapy and targeted therapies—and the critical need for better awareness, screening practices, and research funding to combat this public health threat.
Timestamps
00:00 - Introduction
03:11 - Types of Endometrial Cancer
04:44 - Rising Rates and Risk Factors
08:03 - Disparities in Endometrial Cancer Care
10:37 - Symptoms and Diagnosis
13:52 - Ultrasound vs. Biopsy
16:17 - Challenges in Biopsies
20:58 - Management/Treatment Approaches
23:03 - Geographic Disparities/Access to Care
26:07 - Vaginal Brachytherapy
32:11 - Innovations in Treatment and Research
40:34 - Future Directions: Endometrial Screening
43:54 - AI in Gynecologic Oncology
Resources
Beavis, A. L., Blechter, B., Najjar, O., Fader, A. N., Katebi Kashi, P., & Rositch, A. F. (2023). Identifying women 45 years and younger at elevated risk for endometrial hyperplasia or cancer. Gynecologic Oncology, 174, 98–105. https://doi.org/10.1016/j.ygyno.2023.04.019
Mirza, M. R., Sharma, S., Roed, H., Landrum, L. M., Gilbert, L., Gold, M. A., Novák, Z., Edelson, M., Meirovitz, M., Diaz, J. P., Huygh, G., Buscema, J., Pothuri, B., Eshed, H. D., Coleman, R. L., Slomovitz, B. M., Kostadinov, R., Stevens, S., Ronzino, G., & Powell, M. A. (2024). Post hoc analysis of progression-free survival (PFS) and overall survival (OS) by mechanism of mismatch repair (MMR) protein loss in patients with endometrial cancer (EC) treated with Dostarlimab plus chemotherapy in the ruby trial. Journal of Clinical Oncology, 42(16_suppl), 5606–5606. https://doi.org/10.1200/jco.2024.42.16_suppl.5606
Society of Gynecologic Oncology (SGO):
https://www.sgo.org/
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
Articles
Topics
